| Code | Description | Claims | Beneficiaries | Total Paid |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
22,464 |
18,087 |
$636K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
12,001 |
10,548 |
$417K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
13,932 |
5,063 |
$359K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
10,303 |
9,251 |
$306K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
11,046 |
3,124 |
$267K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
3,592 |
3,249 |
$172K |
| G0378 |
Hospital observation service, per hour |
4,573 |
2,447 |
$156K |
| 70450 |
Computed tomography, head or brain; without contrast material |
3,590 |
3,068 |
$116K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
9,517 |
8,874 |
$111K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
6,898 |
6,309 |
$108K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
628 |
604 |
$78K |
| 93975 |
|
1,164 |
1,063 |
$75K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
17,676 |
6,722 |
$63K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
4,023 |
3,839 |
$61K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
508 |
413 |
$51K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
13,024 |
10,646 |
$48K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
199 |
165 |
$43K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
5,483 |
2,456 |
$41K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,757 |
1,647 |
$38K |
| 71046 |
Radiologic examination, chest; 2 views |
4,578 |
4,226 |
$38K |
| 87631 |
|
587 |
559 |
$36K |
| 80053 |
Comprehensive metabolic panel |
48,058 |
38,939 |
$35K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
5,656 |
5,129 |
$34K |
| 80050 |
General health panel |
12,169 |
11,435 |
$32K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
49,024 |
38,851 |
$32K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
8,738 |
8,307 |
$31K |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
81 |
57 |
$31K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
1,984 |
1,833 |
$28K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
2,223 |
1,794 |
$27K |
| 74018 |
|
1,620 |
1,479 |
$26K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
11,711 |
8,794 |
$26K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
6,862 |
6,385 |
$25K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
958 |
899 |
$25K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
5,544 |
4,419 |
$25K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
5,680 |
3,549 |
$25K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
10,471 |
8,464 |
$23K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
7,415 |
6,273 |
$22K |
| 71045 |
Radiologic examination, chest; single view |
6,208 |
5,456 |
$21K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
143 |
117 |
$20K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
2,347 |
2,185 |
$19K |
| J3490 |
Unclassified drugs |
2,342 |
1,785 |
$18K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
11,180 |
4,663 |
$18K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
11,043 |
9,370 |
$16K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
7,995 |
7,488 |
$16K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
4,704 |
3,616 |
$16K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
657 |
602 |
$16K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
7,992 |
7,487 |
$15K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
623 |
556 |
$14K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,313 |
1,179 |
$13K |
| 84443 |
Thyroid stimulating hormone (TSH) |
12,734 |
11,956 |
$13K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
406 |
373 |
$13K |
| 82728 |
|
5,101 |
4,753 |
$12K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
3,719 |
3,549 |
$12K |
| J2704 |
Injection, propofol, 10 mg |
8,131 |
6,318 |
$11K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
907 |
843 |
$11K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
365 |
351 |
$11K |
| 96376 |
|
4,109 |
2,978 |
$11K |
| 87081 |
|
3,816 |
3,545 |
$11K |
| 97161 |
|
2,451 |
2,229 |
$11K |
| 73110 |
|
890 |
796 |
$11K |
| 80061 |
Lipid panel |
14,432 |
13,736 |
$10K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
8,809 |
7,839 |
$10K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
5,921 |
4,420 |
$10K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
13,531 |
10,108 |
$10K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
8,155 |
6,124 |
$9K |
| 73610 |
|
1,239 |
1,135 |
$9K |
| 76830 |
Ultrasound, transvaginal |
2,089 |
1,935 |
$9K |
| 83516 |
|
1,636 |
1,514 |
$9K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,299 |
988 |
$9K |
| 84703 |
|
7,931 |
6,900 |
$9K |
| 86140 |
|
11,431 |
9,657 |
$9K |
| 97162 |
|
1,580 |
1,419 |
$8K |
| 83690 |
|
8,247 |
7,010 |
$8K |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
1,285 |
1,113 |
$7K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
8,380 |
5,404 |
$7K |
| 84439 |
|
4,878 |
4,513 |
$7K |
| 73630 |
|
1,438 |
1,283 |
$7K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
141 |
136 |
$7K |
| 85027 |
|
8,539 |
7,390 |
$7K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
772 |
369 |
$7K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
572 |
521 |
$7K |
| 82784 |
|
1,933 |
1,799 |
$7K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,655 |
3,526 |
$7K |
| 83605 |
|
2,732 |
2,303 |
$6K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
1,560 |
1,176 |
$6K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
4,607 |
3,069 |
$6K |
| 87077 |
|
5,527 |
4,845 |
$6K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
398 |
378 |
$6K |
| J7050 |
Infusion, normal saline solution, 250 cc |
6,303 |
3,586 |
$6K |
| 81001 |
|
11,011 |
9,519 |
$6K |
| 87040 |
|
972 |
770 |
$5K |
| 86003 |
|
185 |
147 |
$5K |
| 87480 |
|
5,343 |
4,868 |
$5K |
| 87510 |
|
5,342 |
4,867 |
$5K |
| 87660 |
|
5,344 |
4,868 |
$5K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,785 |
1,417 |
$5K |
| 81025 |
|
4,165 |
3,453 |
$4K |
| U0001 |
Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel |
1,667 |
1,569 |
$4K |
| 97535 |
Self-care/home management training, each 15 minutes |
965 |
659 |
$4K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
9,157 |
8,727 |
$4K |
| 73130 |
|
744 |
645 |
$4K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
7,736 |
6,132 |
$4K |
| 76770 |
|
213 |
201 |
$4K |
| 36415 |
Collection of venous blood by venipuncture |
16,021 |
13,219 |
$4K |
| 87070 |
|
3,086 |
2,791 |
$4K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
29 |
27 |
$4K |
| 84145 |
|
1,266 |
1,133 |
$4K |
| 87186 |
|
3,940 |
3,522 |
$4K |
| 73562 |
|
707 |
626 |
$4K |
| 93971 |
|
1,137 |
1,052 |
$3K |
| 83550 |
|
3,232 |
3,028 |
$3K |
| 86900 |
|
4,818 |
3,892 |
$3K |
| 88304 |
|
328 |
283 |
$3K |
| 81003 |
|
6,724 |
6,072 |
$3K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
7,907 |
6,327 |
$3K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
2,789 |
1,667 |
$3K |
| 73140 |
|
174 |
166 |
$3K |
| 82077 |
|
3,443 |
2,508 |
$3K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
842 |
602 |
$3K |
| 80143 |
|
1,610 |
1,291 |
$3K |
| 85379 |
|
2,758 |
2,533 |
$3K |
| 88342 |
|
555 |
481 |
$3K |
| 85652 |
|
5,952 |
5,114 |
$2K |
| 73030 |
|
832 |
750 |
$2K |
| 80179 |
|
1,509 |
1,230 |
$2K |
| 84484 |
|
4,782 |
3,845 |
$2K |
| 87486 |
|
408 |
375 |
$2K |
| 87581 |
|
408 |
375 |
$2K |
| 83735 |
|
3,363 |
2,641 |
$2K |
| 83880 |
|
2,384 |
2,023 |
$2K |
| 82803 |
|
123 |
109 |
$2K |
| 86850 |
|
4,667 |
3,770 |
$2K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
4,472 |
4,272 |
$2K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
258 |
248 |
$2K |
| 99152 |
|
604 |
536 |
$2K |
| 94762 |
|
233 |
170 |
$2K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
3,992 |
3,206 |
$2K |
| 82948 |
|
3,371 |
2,325 |
$2K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
26,733 |
18,190 |
$2K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,369 |
760 |
$2K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
4,837 |
3,663 |
$2K |
| 72100 |
|
730 |
673 |
$2K |
| 83540 |
|
2,247 |
2,080 |
$2K |
| 84403 |
|
932 |
858 |
$2K |
| 84481 |
|
1,806 |
1,683 |
$2K |
| 82607 |
|
2,563 |
2,405 |
$2K |
| 76937 |
|
1,677 |
1,340 |
$2K |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
371 |
281 |
$2K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
96 |
84 |
$2K |
| 85610 |
|
9,133 |
6,245 |
$2K |
| 29125 |
|
157 |
142 |
$2K |
| 84702 |
|
2,644 |
1,763 |
$2K |
| 73080 |
|
80 |
69 |
$2K |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
1,522 |
1,277 |
$2K |
| 86376 |
|
1,234 |
1,143 |
$1K |
| 70486 |
|
35 |
26 |
$1K |
| 90839 |
|
55 |
51 |
$1K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
213 |
197 |
$1K |
| 86901 |
|
4,809 |
3,885 |
$1K |
| 97165 |
|
89 |
84 |
$1K |
| 87205 |
|
2,535 |
2,275 |
$1K |
| 84100 |
|
1,786 |
1,243 |
$1K |
| 73502 |
|
272 |
259 |
$1K |
| 86038 |
|
1,190 |
1,120 |
$1K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
4,028 |
2,726 |
$1K |
| 80076 |
|
757 |
682 |
$1K |
| 92523 |
|
25 |
25 |
$984.99 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
184 |
173 |
$966.32 |
| 87147 |
|
387 |
356 |
$948.81 |
| 86780 |
|
3,187 |
3,015 |
$918.94 |
| 97597 |
|
1,205 |
639 |
$901.16 |
| 85730 |
|
846 |
742 |
$850.89 |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
38 |
37 |
$830.66 |
| 84146 |
|
402 |
381 |
$826.75 |
| 0352U |
|
205 |
196 |
$825.63 |
| 94729 |
|
314 |
297 |
$763.23 |
| 86364 |
|
197 |
189 |
$739.86 |
| C1769 |
Guide wire |
564 |
423 |
$735.09 |
| 83615 |
|
1,298 |
1,020 |
$716.18 |
| 93303 |
Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study |
29 |
29 |
$663.99 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
3,477 |
2,648 |
$658.76 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
581 |
512 |
$637.24 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
74 |
66 |
$602.68 |
| 84550 |
|
1,087 |
949 |
$588.29 |
| 86803 |
|
4,111 |
3,922 |
$576.78 |
| 82670 |
|
311 |
281 |
$560.08 |
| 97035 |
|
2,725 |
1,171 |
$543.17 |
| J2060 |
Injection, lorazepam, 2 mg |
2,738 |
2,098 |
$539.31 |
| 12011 |
|
13 |
12 |
$532.29 |
| 83970 |
|
283 |
255 |
$507.65 |
| 86308 |
|
214 |
204 |
$474.31 |
| 82570 |
|
2,785 |
2,570 |
$458.18 |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
57 |
54 |
$450.00 |
| 82550 |
|
847 |
701 |
$448.38 |
| 94726 |
|
259 |
242 |
$442.90 |
| 96367 |
|
935 |
521 |
$441.75 |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
231 |
225 |
$441.26 |
| A4216 |
Sterile water, saline and/or dextrose, diluent/flush, 10 ml |
2,146 |
1,525 |
$417.36 |
| 86431 |
|
893 |
846 |
$408.58 |
| 73590 |
|
44 |
39 |
$407.34 |
| 76801 |
|
84 |
75 |
$407.15 |
| 97116 |
|
124 |
66 |
$393.96 |
| 87507 |
|
56 |
54 |
$370.47 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
797 |
714 |
$361.09 |
| 73090 |
|
13 |
13 |
$342.24 |
| 87075 |
|
529 |
463 |
$340.31 |
| 90715 |
|
258 |
233 |
$337.22 |
| 51798 |
|
32 |
29 |
$303.45 |
| 82043 |
|
2,502 |
2,382 |
$277.01 |
| 83001 |
|
233 |
217 |
$276.38 |
| 94799 |
|
30 |
28 |
$261.79 |
| 83630 |
|
135 |
124 |
$259.59 |
| 87046 |
|
39 |
36 |
$244.17 |
| 93325 |
|
50 |
48 |
$239.35 |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
4,006 |
3,847 |
$239.12 |
| 86762 |
|
1,146 |
1,075 |
$235.64 |
| 87340 |
|
1,810 |
1,698 |
$229.44 |
| 82247 |
|
169 |
109 |
$221.98 |
| 76536 |
|
51 |
50 |
$207.43 |
| 87338 |
|
25 |
25 |
$198.10 |
| S0028 |
Injection, famotidine, 20 mg |
235 |
179 |
$193.11 |
| 82785 |
|
20 |
15 |
$192.00 |
| 85007 |
|
460 |
362 |
$188.22 |
| 80178 |
|
527 |
441 |
$182.31 |
| 82746 |
|
352 |
321 |
$180.80 |
| 82375 |
|
420 |
395 |
$178.79 |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
145 |
130 |
$173.04 |
| 86769 |
|
96 |
95 |
$168.52 |
| 85018 |
|
590 |
514 |
$168.49 |
| 99153 |
Mod sedat endo service >5yrs |
84 |
73 |
$160.63 |
| 92567 |
|
58 |
54 |
$159.80 |
| 80305 |
|
274 |
223 |
$159.13 |
| 93320 |
|
33 |
33 |
$155.98 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
3,340 |
1,627 |
$146.92 |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
13 |
12 |
$142.80 |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
112 |
98 |
$142.66 |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
175 |
142 |
$138.55 |
| J1790 |
Injection, droperidol, up to 5 mg |
611 |
528 |
$132.75 |
| 86480 |
|
33 |
32 |
$120.48 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
414 |
303 |
$118.22 |
| 87427 |
|
27 |
24 |
$108.36 |
| 82533 |
|
120 |
102 |
$105.38 |
| 87045 |
|
54 |
48 |
$103.76 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
356 |
305 |
$99.72 |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
2,881 |
2,772 |
$97.38 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
14 |
12 |
$87.71 |
| 84156 |
|
832 |
669 |
$87.19 |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
184 |
177 |
$76.50 |
| 83721 |
|
275 |
266 |
$69.08 |
| 36410 |
|
925 |
722 |
$67.13 |
| 72040 |
|
27 |
25 |
$62.99 |
| 82274 |
|
15 |
13 |
$61.91 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
229 |
181 |
$60.97 |
| 87467 |
|
578 |
559 |
$60.14 |
| 82977 |
|
45 |
39 |
$51.12 |
| 86255 |
|
63 |
58 |
$46.86 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
144 |
120 |
$46.13 |
| 90686 |
|
387 |
370 |
$43.12 |
| 86706 |
|
375 |
357 |
$41.77 |
| 82950 |
|
661 |
637 |
$36.72 |
| 83002 |
|
15 |
14 |
$36.00 |
| 94760 |
|
26 |
24 |
$30.60 |
| A9270 |
Non-covered item or service |
10,036 |
4,224 |
$29.28 |
| 86141 |
|
59 |
58 |
$25.17 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
47 |
41 |
$23.80 |
| Q0163 |
Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen |
194 |
151 |
$22.95 |
| 80069 |
|
15 |
12 |
$22.38 |
| 82565 |
|
170 |
155 |
$13.21 |
| 82248 |
|
46 |
40 |
$13.02 |
| 86705 |
|
243 |
216 |
$10.37 |
| 82947 |
|
16 |
12 |
$10.12 |
| 86709 |
|
149 |
127 |
$9.91 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
67 |
62 |
$5.66 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
15 |
13 |
$5.60 |
| 83050 |
|
162 |
156 |
$2.93 |
| 96118 |
|
60 |
48 |
$0.00 |
| 92557 |
|
40 |
38 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
44 |
34 |
$0.00 |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
60 |
54 |
$0.00 |
| 86200 |
|
111 |
105 |
$0.00 |
| 84155 |
|
30 |
12 |
$0.00 |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
781 |
414 |
$0.00 |
| 77336 |
|
32 |
13 |
$0.00 |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
54 |
48 |
$0.00 |
| 76376 |
|
54 |
49 |
$0.00 |
| 0097U |
|
14 |
14 |
$0.00 |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
117 |
109 |
$0.00 |
| 11719 |
|
13 |
12 |
$0.00 |
| 87641 |
|
192 |
160 |
$0.00 |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
225 |
211 |
$0.00 |
| 90653 |
|
109 |
105 |
$0.00 |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
96 |
93 |
$0.00 |
| 93296 |
|
16 |
14 |
$0.00 |
| 84165 |
|
31 |
27 |
$0.00 |
| 94060 |
|
44 |
40 |
$0.00 |
| 59025 |
Fetal non-stress test |
14 |
12 |
$0.00 |
| Q0091 |
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory |
51 |
47 |
$0.00 |
| 17110 |
|
17 |
16 |
$0.00 |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
20 |
19 |
$0.00 |
| 80074 |
|
105 |
101 |
$0.00 |
| 80164 |
|
15 |
13 |
$0.00 |
| 89051 |
|
15 |
12 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
238 |
189 |
$0.00 |
| 87076 |
|
16 |
12 |
$0.00 |
| 81002 |
|
38 |
35 |
$0.00 |
| S9443 |
Lactation classes, non-physician provider, per session |
36 |
14 |
$0.00 |
| 90837 |
Psychotherapy, 53 minutes with patient |
27 |
19 |
$0.00 |
| J1630 |
Injection, haloperidol, up to 5 mg |
145 |
115 |
$0.00 |
| 36591 |
|
300 |
198 |
$0.00 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
74 |
66 |
$0.00 |
| 84153 |
|
1,200 |
1,121 |
$0.00 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
34 |
26 |
$0.00 |
| 96415 |
|
207 |
145 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
491 |
473 |
$0.00 |
| 90694 |
|
75 |
72 |
$0.00 |
| S9445 |
Patient education, not otherwise classified, non-physician provider, individual, per session |
297 |
196 |
$0.00 |
| 88307 |
|
146 |
97 |
$0.00 |
| G0379 |
Direct admission of patient for hospital observation care |
16 |
12 |
$0.00 |
| 84144 |
|
247 |
214 |
$0.00 |
| Q3014 |
Telehealth originating site facility fee |
35 |
28 |
$0.00 |
| 94010 |
|
12 |
12 |
$0.00 |
| 96161 |
|
60 |
58 |
$0.00 |
| 96119 |
|
38 |
35 |
$0.00 |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
12 |
12 |
$0.00 |
| 76870 |
|
14 |
13 |
$0.00 |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
23 |
15 |
$0.00 |
| 96127 |
|
59 |
56 |
$0.00 |
| 96120 |
|
36 |
32 |
$0.00 |
| 84402 |
|
15 |
12 |
$0.00 |
| 87522 |
Neg quan hep c or qual rna |
49 |
48 |
$0.00 |
| 12002 |
|
15 |
15 |
$0.00 |
| 58300 |
|
14 |
12 |
$0.00 |
| 70496 |
|
15 |
12 |
$0.00 |
| 12001 |
|
12 |
12 |
$0.00 |